Inventprise Press Release Archive

Inventprise CEO Attends 2nd Global Forum on Childhood Pneumonia
Every Breath Counts: Pneumococcal Conjugate Vaccine Scorecard 2022
PATH: Inventprise’s Expanded-coverage Pneumococcal Vaccine Enters the Clinic
Precision Vaccinations: Pneumococcal Vaccines 2023
Gates Notes: A Promising New Vaccine to Protect Children from Their #1 Killer
Biospace: Gates Foundation Pours $90 Million into Promising New Pneumococcal Vaccine
GeekWire: Seattle-Area Startup Inventprise Gets Backing from Gates Foundation for Pneumonia Shot